In a three-way test, a 50-year-old drug has edged out two newer ones for treatment of a kind of epilepsy that causes children to gaze off into space.
The new study provides much-needed data for doctors, since all three medications have been used for years without being compared against one another in a controlled trial.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.